NCT05507047

Emdogain Implementation With Transcrestal Sinus Lifting and Dental Implant Placement

The Evaluation of Enamel Matrix Derivative on the Bone Regenerative Potential of the Dental Implant With Transcrestal Sinus Lifting Technique: Randomized-Controlled CBCT Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: T.C. Dumlupınar Üniversitesi · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to evaluate the clinical and radiographic results of implants placed using osteotome sinus floor elevation (OSFE) with and without simultaneous enamel matrix derivative (EMD) application.

Detailed description

Twenty-four patients will be randomly assigned into two groups: Group I: (EMD+OSFE) (n=20 implants, 13 patients) OSFE with EMD application, and Group II 8OSFE): (n=20 implants, 11 patients) OSFE without EMD application. The patients will be recall at 3- and 12- months after surgery. The residual bone height (RBH), implant protrusion length (IPL), peri-implant sinus bone level (SBL), endo-sinus bone gain (ESBG), implant stability and peri-implant bone density values (Hounsfield units) will be assessed.

Conditions

• Osseointegration Failure of Dental Implant
• Bone Density Increased

Interventions

Type	Name	Description
DRUG	Enamel Matrix Protein	Enamel matrix derivated is used with transcrestal sinus lifting treatment

Timeline

• Start date: 2017-01-01
• Primary completion: 2020-01-01
• Completion: 2020-12-01
• First posted: 2022-08-18
• Last updated: 2022-08-18

Locations

1 site across 1 country: Turkey (Türkiye)